More than 1 million in financial support allows CNS Therapy to fast-track the development of their drug-free pain relief management solution that combines the use of their patented medical device with interactive therapy.
We are delighted to see the success achieved by one of our DayOne Tech alumni companies CNS Therapy. Located in the Switzerland Innovation Park Basel Area – site Jura, the company has successfully secured CHF 1,000,000 from private investors in a seed round, complemented by an additional non-dilutive financial support of CHF 139,200 from the canton of Jura.
A patented medical device
While many traditional treatments for chronic pain rely on medications and implants, CNS Therapy offers a different kind of relief to chronic pain patients using innovative methods. Their primary offering is the Systolic Extinction Therapy (SET), a patented medical device combined with interactive therapy. Through SET, they’ve achieved impressive results, with 82% of treated female fibromyalgia patients maintaining pain freedom after a year. Their ambition is to commercialize this approach, providing a non-invasive, drug-free alternative to chronic pain sufferers in Switzerland and beyond.
Winner of the DayOne Tech accelerator
As a winner of the 2022 DayOne Tech accelerator, CNS Therapy’s dedication to revolutionizing pain relief mirrors DayOne Tech’s mission to support groundbreaking medical advancements.
This funding milestone is a significant step for CNS Therapy and underscores the transformative potential of the medtech space. At DayOne Tech, we’re eager to witness the future impact of such innovations.
About DayOne Tech accelerator program
DayOne Tech is a 12-month accelerator program for medtech ventures in the Jura. The accelerator collaborates with strategic medtech stakeholders and partners, providing startups like CNS Therapy the environment and support they need to reach global markets.
Check out the video “Meet our residents: An interview with CNS Therapy” at Switzerland Innovation Park, our coworking space, and innovation hub.
